The FDA is tracking new chemical entity approvals while US government support is being withdrawn.
1 report, 1 independent
Updated Jul 27
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The FDA is tracking new chemical entity approvals while US government support is being withdrawn.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
TB Alliance
organization
Nothing else this week.
Related events
- FDA approval is the goal for product candidates from Daré Bioscience, Inc.
- FDA oversees drug trials in the US and Israel for Clearmind Medicine Inc., which is listed on Nasdaq.
- PAVmed is facing the requirement of regulatory clearance for its company products, while also attracting institutional investment interest.
- AMA urges FDA to maintain standards as federal government implements marijuana rescheduling order amid GAO findings of regulatory deficiencies.
- DBV Technologies is seeking regulatory acceptance for its product from the FDA.
Coverage
Newest first; wire copies grouped- devpolicy.orgA not-for-profit medicine development model to address global health inequities - Devpolicy Blog from the Development Policy Centre